Hepatitis B Virus Genotype B and High Expression of Interferon Alpha Receptor ? Subunit are Associated With Better Response to Pegylated Interferon Alpha 2a in Chinese Patients With Chronic Hepatitis B Infection

Authors

Ya-Bin Guo, You-Fu Zhu, An-Shen Chen, Mu-Xiu Zhou, Zhi Li, Li-Tong Xu, Xiao-Ju Ma, Fu-Ming Yan, he fan1,*
1Department of Infectious Disease, The People’s Liberation Army 161 Hospital, Wuhan, China
*Corresponding Author: He-Bin Fan, Department of Infectious Disease, The People’s Liberation Army 161 Hospital, Wuhan, 430010, Hubei, China. Tel: +86-2750169074, Fax: +86-2750169007 Email: [email protected]

Hepatitis Monthly:Vol. 12, issue 5; 333-338
Published online:May 31, 2012
Article type:Research Article
Received:Mar 22, 2012
Accepted:Apr 24, 2012
How to Cite:Guo Y, Zhu Y, Chen A, Zhou M, Li Z, et al. Hepatitis B Virus Genotype B and High Expression of Interferon Alpha Receptor ? Subunit are Associated With Better Response to Pegylated Interferon Alpha 2a in Chinese Patients With Chronic Hepatitis B Infection. Hepat Mon. 2012;12(5):. doi: https://doi.org/10.5812/hepatmon.6173

Abstract

 

Background: Hepatitis B virus (HBV) is one of leading causes of various hepatic diseases including acute and chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Hundreds of million people worldwide are infected by HBV, chronically.
Objectives: This study in conducted to investigate the in?uence of Hepatitis B virus (HBV) genotypes and type I IFN-αreceptor β subunit (IFNAR2) expression in liver on response to treatment with pegylated IFN-α-2a (Peg-IFN-α-2a) for chronic hepatitis B infection.
Patients and Methods: In this study, 65 eligible patients with chronic hepatitis B disease were enrolled. HBV genotypes of these patients were analyzed by using PCR-RFLP of the surface gene of HBV. The expression of IFNAR2 in the liver was immune histochemically investigated using anti-IFNAR2 antibody. All immune histochemical slides were read semi-quantitatively by image analysis. Chronic hepatitis B patients were treated with Peg-IFN-α2a therapy for a 48-week period and followed up for 24 weeks. Baseline characteristics and sustained viral response (SVR) to Peg-IFN-α-2a therapy were evaluated.
Results: 55 % of patients exhibited HBV genotype B and 31.7 % patients exhibited HBV genotypes C infections. After treatment with Peg-IFN-α-2a, SVR was achieved in 66.7 % of patients with HBV genotype B and in 26.3 % of patients with HBV genotype C (P = 0.009). Semiquantitative and the image analysis indicated by gray level values revealed a higher IFNAR2 expression in the group with severe in?ammation (P < 0.001). Patients’ high IFNAR2 protein expression had a signi?cant impact on SVR to Peg-IFN-α-2a therapy (P = 0.028).
Conclusions: HBV genotype B and high expression of IFNAR2 in the liver of chronic hepatitis B patients are closely associated with better response to Peg-IFN-α-2a therapy in chronic hepatitis B disease.

Implication for health policy/practice/research/medical education: 
Hepatitis B Virus genotype B and high expression of interferon alpha receptor β subunit may be considered as a predictor of response to interferon antiviral therapy in HBV patients and study of this article is recommended to the hepatologists, virologists, gastroentestinalist and other researchers.
Please cite this paper as: 
Fan HB, Guo YB, Zhu YF, Chen AS, Zhou MX, Li Z, et al. Hepatitis B Virus Genotype B and High Expression of Interferon Alpha Receptor β Subunit are Associated With Better Response to Pegylated Interferon Alpha 2a in Chinese Patients With Chronic Hepatitis B Infection. Hepat Mon. 2012;12(5): 333-8. DOI: 10.5812/hepatmon.6173

Copyright © 2012 Kowsar Corp. All rights reserved.

 

Fulltext

Full text is available in PDF

Copyright

© 2012, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

1
Feb
2017

Higher Serum Levels of Type I Interferon Receptor in Adults with Chronic Hepatitis B Leading to Hepatitis B Surface Antigen Clearance

Ashraf Mohamadkhani,
Sima Besharat,
Golnosh Gol-Jah Rad,
Akbar Pour Dadash Asiabar,
Gholamreza Roshandel,
Akram Pourshams
,et al.

Mohamadkhani A, Besharat S, Gol-Jah Rad G, Pour Dadash Asiabar A, Roshandel G, et al. Higher Serum Levels of Type I Interferon Receptor in Adults with Chronic Hepatitis B Leading to Hepatitis B Surface Antigen Clearance. Jundishapur J Microbiol. 2017;10(3):e41319. doi: https://doi.org/10.5812/jjm.41319

31
May
2009

Antibody against Interferon-α 2b in Serum of the Patients with Chronic Hepatitis C and its Clinical Significance: A Clinical Trial

wangjian wangjian,
Wang Pingping,
Xiang Guiju,
wangjian wangjian,
Wang Pingping,
Xiang Guiju

wangjian W, Pingping W, Guiju X, wangjian W, Pingping W, et al. Antibody against Interferon-α 2b in Serum of the Patients with Chronic Hepatitis C and its Clinical Significance: A Clinical Trial. Hepat Mon. 2009;9(2):e92963. doi:

31
Jan
2011

Hepatitis B Virus DNA Level as Predictor of Response to Therapy with Interferon-alpha-2b (PDferon) in Chronic Hepatitis B Infection

Seyed Moayed Alavian,
Seyed Mohammad Miri,
Mohammad Javad Behzadnia

Alavian SM, Miri SM, Behzadnia MJ. Hepatitis B Virus DNA Level as Predictor of Response to Therapy with Interferon-alpha-2b (PDferon) in Chronic Hepatitis B Infection. Arch Clin Infect Dis. 2011;6(1):. doi:

1
Mar
2014

Interferon Alpha-2b Therapy in Chronic Hepatitis Delta

Maryam Keshvari,
Seyed Moayed Alavian,
Heidar Sharafi,
Gharib Karimi,
Mohammad Gholami Fesharaki

Keshvari M, Alavian SM, Sharafi H, Karimi G, Gholami Fesharaki M. Interferon Alpha-2b Therapy in Chronic Hepatitis Delta. Hepat Mon. 2014;14(3):e15729. doi: https://doi.org/10.5812/hepatmon.15729

31
Mar
2015

Pegylated Interferon α Therapy in Chronic Delta Hepatitis: A One-Center Experience

Ibrahim Halil Bahcecioglu,
Murat Ispiroglu,
Ulvi Demirel,
Mehmet Yalniz

Bahcecioglu IH, Ispiroglu M, Demirel U, Yalniz M. Pegylated Interferon α Therapy in Chronic Delta Hepatitis: A One-Center Experience. Hepat Mon. 2015;15(3):e24366. doi: https://doi.org/10.5812/hepatmon.24366

More by these authors

Ya-Bin GuoPubMedScholar
You-Fu ZhuPubMedScholar
An-Shen ChenPubMedScholar
Mu-Xiu ZhouPubMedScholar
Li-Tong XuPubMedScholar
Xiao-Ju MaPubMedScholar
Fu-Ming YanPubMedScholar
Share
Cited by
Metrics